Clik here to view.
Orthocell Receives Approval for Human Nerve Regeneration Study Using CelGro®
PERTH, Australia Regenerative medicine company Orthocell has been granted ethics approval for a human study examining the effectiveness of its CelGro® collagen medical device, to guide and promote...
View ArticleClik here to view.
Mammoplasty Using Implants, Safety Must Come First! TL Plastic Surgery
SEOUL, South Korea As mammoplasty using implants is getting popular, people started to pay more attention to its safety. It’s a complex procedure as it covers not only breast augmentation but also...
View ArticleClik here to view.
Temasek Invests $250M in Columbia Pacific’s China Operations
SEATTLE Columbia Pacific Management, one of the largest and fastest-growing healthcare providers in Asia, is partnering with Temasek, an investment company based in Singapore, on a joint venture...
View ArticleClik here to view.
QuintilesIMS荣获临床研究单位协会颁发的2016年度鹰奖
康涅狄格州丹伯利和北卡罗莱纳州研究三角园区 (美国商业资讯)–QuintilesIMS (NYSE:Q)今天宣布，该公司获得临床研究单位协会(SCRS)颁发的2016年度鹰奖，这是该公司连续第四年获得该奖项。该奖项由研究单位提名，在每年一次的SCRS研究单位解决方案峰会上颁奖，以表彰那些致力于通过身先士卒、专业精神和正直诚实与研究单位构建积极关系的合同研究组织(CRO)和生物制药申办商。...
View ArticleClik here to view.
クインタイルズIMSがソサエティー・フォー・クリニカル・リサーチ・サイトの2016年イーグル・アワードを受賞
米コネティカット州ダンバリー & ノースカロライナ州リサーチ・トライアングル・パーク （ビジネスワイヤ） —...
View ArticleClik here to view.
AGS FX Creations 电动赛车造型背包系列
香港 (美国商业资讯)–创意时尚背包品牌AGS FX Creations 较早前为世界级赛车比赛 “香港电讯电动方程式”在香港的赛事设计了一系列以赛车为主题的限量版赛车造型背包，并于预售期间大获市场好评。近日，品牌除宣布系列将于11月正式发售外，更介绍了最新的秋冬新色设计，令人热切期待。 糅合创新科技与极限运动 AGS FX Creations...
View ArticleClik here to view.
AGS FX Creations Motorsport Backpack
HONG KONG Placing innovation and appeal at its core, AGS FX Creations had the honor in designing a series of motorsport backpack for the Hong Kong Formula E venue held in October. As November is now...
View ArticleClik here to view.
First Patient is Enrolled in Global STEMTRA Trial for Traumatic Brain Injury...
MOUNTAIN VIEW, Calif. & TOKYO SanBio Co., Ltd., a scientific leader in regenerative medicine for neurological disorders, today announced that the first patient in Japan was enrolled in the...
View ArticleClik here to view.
Astellas Reports First Half FY2016 Financial Results, Revises Fiscal Year...
TOKYO Astellas Pharma Inc. (TOKYO:4503, President and CEO: Yoshihiko Hatanaka, “Astellas”) today announced financial results for the first six months of fiscal year 2016 ending March 31, 2017...
View ArticleClik here to view.
Takeda Reports First Half FY2016 Results and Raises Full Year Profit Guidance
OSAKA, Japan Takeda Pharmaceutical Company Limited (TOKYO:4502): Strong first half results led by Growth Drivers Underlying Revenue grew +7.4%, led by a +15.3% increase of Takeda’s Growth...
View ArticleClik here to view.
2016年度上期（4‐9月期）の連結業績について当期利益およびEPSの年間予想、実質的なコア・アーニングスのマネジメントガイダンスを上方修正
大阪 （ビジネスワイヤ） — 武田薬品工業株式会社 （東証：4502）： タケダ成長ドライバーが力強い上期実績を牽引 売上収益の実質的な成長は、タケダ成長ドライバー（消化器系疾患領域、オンコロジー、中枢神経系疾患領域、新興国事業）の＋15.3％の伸長により、対前年同期＋7.4％を達成。財務ベースでは、為替影響（△8.6ポイント）や事業等の売却影響（△4.7ポイント）により対前年同期△5.9％...
View ArticleClik here to view.
事実を直視する：脳卒中は治療可能
印ハイデラバード （ビジネスワイヤ） — 世界中では2秒に1人のペースで誰かが脳卒中を起こしています。脳卒中は世界で障害の主因の第1位、死亡の主因の第2位を占めています。 脳卒中の正しい治療は命を救うことができますが、世界では命を救う治療へのアクセスは誰もが同じというわけではありません。...
View ArticleClik here to view.
面对事实：卒中是可以治疗的
印度海得拉巴 (美国商业资讯) — 世界上每2秒钟就有人发生卒中。卒中是全球第一致残原因和和第二死因。 正确的卒中医护能够挽救生命，但全球并非每个人都能获得平等的挽救生命的治疗。 今天是世界卒中日（2016年10月29日星期六），世界卒中组织(WSO)呼吁全球行动起来减少卒中治疗中的不平等，以帮助挽救数百万生命。 在印度海得拉巴召开的世界卒中大会上，WSO主席Stephen...
View ArticleClik here to view.
World-Leading Experts Collaborate at Cochlear’s Global Research Symposium
SYDNEY There are 360 million people living with disabling hearing loss worldwide and this figure is set to increase significantly to 1.2 billion by 2050.,12 To prepare for the expanding needs of...
View ArticleClik here to view.
武田公布2016财年上半年业绩并提高全年利润指引
日本大阪 (美国商业资讯)–武田药品工业株式会社(TOKYO:4502)： 强劲的上半年业绩得益于增长引擎 得益于武田增长引擎（胃肠药、肿瘤药、CNS和新兴市场）+15.3%的增长，基础营收增长+7.4%。 由于不利的汇率影响（-8.6个百分点）和剥离影响（-4.7个百分点），报告的营收下降5.9%。...
View ArticleClik here to view.
Pfizer’s Prevenar 13® Receives Approval For Use in Infants and Children in China
NEW YORK Pfizer China announced today that it has received approval from the Chinese Food and Drug Administration (CFDA) to market its pneumococcal 13-valent conjugate vaccine, Prevenar 13®, in...
View ArticleClik here to view.
Takeda to Present Broad Range of Clinical Data During 58th American Society...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that it will present a total of 16 company-sponsored abstracts at the 58th American Society of...
View ArticleClik here to view.
Evaluate Ltd Receives Significant Investment from HgCapital to Expand...
LONDON & BOSTON & SAN FRANCISCO & TOKYO Evaluate Ltd, the life science commercial intelligence firm, today announced that it has received significant investment from HgCapital’s Mercury...
View ArticleTaro Provides Results for September 30, 2016
HAWTHORNE, N.Y. Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today provided unaudited financial results for the three and six months ended September 30, 2016. Quarter...
View ArticleClik here to view.
Media’s Positive Role Highlighted at Glittering Aster Media Awards Ceremony
DUBAI, United Arab Emirates The inaugural edition of Aster Media Awards saw luminaries emphasizing the critical role of media in ensuring inclusiveness in society and reiterated the immense impact...
View Article